Hello, everyone, and how was your weekend? We hope you are feeling refreshed and invigorated this morning, even if it is an abbreviated week on this side of the pond. After all, there is always much to do. Our to-do list, for instance, includes the usual menu of phone calls and reading. So, time to dig in. This calls, of course, for a cup of stimulation and we invite you to join us. So grab a cup and peruse a few tidbits that we have gathered. Hope your day goes well and do stay in touch...
Icahn Offers Unusual Bonus For Nominee In Forest Labs Fight (Reuters)
Alzheimer's Initiative Begins DNA Patient Mapping (Bloomberg News)
Glaxo Combo Lung Drug Shows Positive Trial Results (Reuters)
AstraZeneca Eyes More Deals After Amylin (Financial Times)
Glaxo Updates Zofran Label Over Safety Concerns (Reuters)
Roche Ordered To Pay $18M To Former Accutane Patients (Bloomberg News)
UK Issues Draft Guidance On Clinical Trial Insurance (Outsourcing Pharma)
Pharma Fails To Maintain R&D Spending Levels In Canada (Pharma Times)
India Moves Toward Making Marketing Code Mandatory (Economic Times)
EDITOR'S NOTE: Please check this post for updates during the day
sunrise pic thx to benimoto on flickr
3 Comments
He lost the case last year. You can read about that here..
http://www.pharmalot.com/2011/04/its-curtains-on-actors-accutane-lawsuit/
Cheers ed